Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Prostate Cancer Antigen 3 Test Supply, Demand and Key Producers, 2026-2032

  • RnM4665858
    • |
  • 19 January, 2026
    • |
  • Global
    • |
  • 93 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

The global Prostate Cancer Antigen 3 Test market size is expected to reach $ 111 million by 2032, rising at a market growth of 8.9% CAGR during the forecast period (2026-2032).
The prostate cancer antigen 3 gene (PCA3) test is used to assess your risk of developing prostate cancer. It is not used to make a diagnosis of prostate cancer. It is primarily used to determine whether your elevated prostate-specific antigen (PSA) levels are the result of prostate cancer. Prostate cancer is a type of cancer that develops in the prostate gland of men and is increasing at a significant rate each year. This cancer is commonly found in the elderly population, and it can have serious consequences such as blood in the sperm, bone pain, and erectile dysfunction, among others. As a result, early detection is required to avoid it at an early stage.
The Global key players of Prostate Cancer Antigen 3 Test include Hologic, Thermo Fisher Scientific, MDxHealth, etc. The top three players hold a share about 77%. US & Canada is the largest market, and has a share about 37%. In terms of product type, RT-PCR is the largest segment, which occupied for a share of about 87%. For application, Hospital is the largest segment, which has a share about 61%.
This report studies the global Prostate Cancer Antigen 3 Test demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Prostate Cancer Antigen 3 Test, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prostate Cancer Antigen 3 Test that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Prostate Cancer Antigen 3 Test total market, 2021-2032, (USD Million)
Global Prostate Cancer Antigen 3 Test total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Prostate Cancer Antigen 3 Test total market, key domestic companies, and share, (USD Million)
Global Prostate Cancer Antigen 3 Test revenue by player, revenue and market share 2021-2026, (USD Million)
Global Prostate Cancer Antigen 3 Test total market by Type, CAGR, 2021-2032, (USD Million)
Global Prostate Cancer Antigen 3 Test total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Prostate Cancer Antigen 3 Test market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hologic, Thermo Fisher Scientific, MDxHealth, Exosome Diagnostics GmbH, Copyright Creative Diagnostics, Lytech, YUBO, MicroDiag Biomedicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Prostate Cancer Antigen 3 Test market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Prostate Cancer Antigen 3 Test Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Prostate Cancer Antigen 3 Test Market, Segmentation by Type:
RT-PCR
ELISA Test
Global Prostate Cancer Antigen 3 Test Market, Segmentation by Application:
Hospital
Diagnosis Center
Other
Companies Profiled:
Hologic
Thermo Fisher Scientific
MDxHealth
Exosome Diagnostics GmbH
Copyright Creative Diagnostics
Lytech
YUBO
MicroDiag Biomedicine
Key Questions Answered
1. How big is the global Prostate Cancer Antigen 3 Test market?
2. What is the demand of the global Prostate Cancer Antigen 3 Test market?
3. What is the year over year growth of the global Prostate Cancer Antigen 3 Test market?
4. What is the total value of the global Prostate Cancer Antigen 3 Test market?
5. Who are the Major Players in the global Prostate Cancer Antigen 3 Test market?
6. What are the growth factors driving the market demand?


1 Supply Summary

  • 1.1 Prostate Cancer Antigen 3 Test Introduction
  • 1.2 World Prostate Cancer Antigen 3 Test Market Size & Forecast (2021 & 2025 & 2032)
  • 1.3 World Prostate Cancer Antigen 3 Test Total Market by Region (by Headquarter Location)
    • 1.3.1 World Prostate Cancer Antigen 3 Test Market Size by Region (2021-2032), (by Headquarter Location)
    • 1.3.2 United States Based Company Prostate Cancer Antigen 3 Test Revenue (2021-2032)
    • 1.3.3 China Based Company Prostate Cancer Antigen 3 Test Revenue (2021-2032)
    • 1.3.4 Europe Based Company Prostate Cancer Antigen 3 Test Revenue (2021-2032)
    • 1.3.5 Japan Based Company Prostate Cancer Antigen 3 Test Revenue (2021-2032)
    • 1.3.6 South Korea Based Company Prostate Cancer Antigen 3 Test Revenue (2021-2032)
    • 1.3.7 ASEAN Based Company Prostate Cancer Antigen 3 Test Revenue (2021-2032)
    • 1.3.8 India Based Company Prostate Cancer Antigen 3 Test Revenue (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Prostate Cancer Antigen 3 Test Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Major Market Trends

2 Demand Summary

  • 2.1 World Prostate Cancer Antigen 3 Test Consumption Value (2021-2032)
  • 2.2 World Prostate Cancer Antigen 3 Test Consumption Value by Region
    • 2.2.1 World Prostate Cancer Antigen 3 Test Consumption Value by Region (2021-2026)
    • 2.2.2 World Prostate Cancer Antigen 3 Test Consumption Value Forecast by Region (2027-2032)
  • 2.3 United States Prostate Cancer Antigen 3 Test Consumption Value (2021-2032)
  • 2.4 China Prostate Cancer Antigen 3 Test Consumption Value (2021-2032)
  • 2.5 Europe Prostate Cancer Antigen 3 Test Consumption Value (2021-2032)
  • 2.6 Japan Prostate Cancer Antigen 3 Test Consumption Value (2021-2032)
  • 2.7 South Korea Prostate Cancer Antigen 3 Test Consumption Value (2021-2032)
  • 2.8 ASEAN Prostate Cancer Antigen 3 Test Consumption Value (2021-2032)
  • 2.9 India Prostate Cancer Antigen 3 Test Consumption Value (2021-2032)

3 World Prostate Cancer Antigen 3 Test Companies Competitive Analysis

  • 3.1 World Prostate Cancer Antigen 3 Test Revenue by Player (2021-2026)
  • 3.2 Industry Rank and Concentration Rate (CR)
    • 3.2.1 Global Prostate Cancer Antigen 3 Test Industry Rank of Major Players
    • 3.2.2 Global Concentration Ratios (CR4) for Prostate Cancer Antigen 3 Test in 2025
    • 3.2.3 Global Concentration Ratios (CR8) for Prostate Cancer Antigen 3 Test in 2025
  • 3.3 Prostate Cancer Antigen 3 Test Company Evaluation Quadrant
  • 3.4 Prostate Cancer Antigen 3 Test Market: Overall Company Footprint Analysis
    • 3.4.1 Prostate Cancer Antigen 3 Test Market: Region Footprint
    • 3.4.2 Prostate Cancer Antigen 3 Test Market: Company Product Type Footprint
    • 3.4.3 Prostate Cancer Antigen 3 Test Market: Company Product Application Footprint
  • 3.5 Competitive Environment
    • 3.5.1 Historical Structure of the Industry
    • 3.5.2 Barriers of Market Entry
    • 3.5.3 Factors of Competition
  • 3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)

  • 4.1 United States VS China: Prostate Cancer Antigen 3 Test Revenue Comparison (by Headquarter Location)
    • 4.1.1 United States VS China: Prostate Cancer Antigen 3 Test Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
    • 4.1.2 United States VS China: Prostate Cancer Antigen 3 Test Revenue Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States Based Companies VS China Based Companies: Prostate Cancer Antigen 3 Test Consumption Value Comparison
    • 4.2.1 United States VS China: Prostate Cancer Antigen 3 Test Consumption Value Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Prostate Cancer Antigen 3 Test Consumption Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States Based Prostate Cancer Antigen 3 Test Companies and Market Share, 2021-2026
    • 4.3.1 United States Based Prostate Cancer Antigen 3 Test Companies, Headquarters (States, Country)
    • 4.3.2 United States Based Companies Prostate Cancer Antigen 3 Test Revenue, (2021-2026)
  • 4.4 China Based Companies Prostate Cancer Antigen 3 Test Revenue and Market Share, 2021-2026
    • 4.4.1 China Based Prostate Cancer Antigen 3 Test Companies, Company Headquarters (Province, Country)
    • 4.4.2 China Based Companies Prostate Cancer Antigen 3 Test Revenue, (2021-2026)
  • 4.5 Rest of World Based Prostate Cancer Antigen 3 Test Companies and Market Share, 2021-2026
    • 4.5.1 Rest of World Based Prostate Cancer Antigen 3 Test Companies, Headquarters (Province, Country)
    • 4.5.2 Rest of World Based Companies Prostate Cancer Antigen 3 Test Revenue (2021-2026)

5 Market Analysis by Type

  • 5.1 World Prostate Cancer Antigen 3 Test Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 RT-PCR
    • 5.2.2 ELISA Test
  • 5.3 Market Segment by Type
    • 5.3.1 World Prostate Cancer Antigen 3 Test Market Size by Type (2021-2026)
    • 5.3.2 World Prostate Cancer Antigen 3 Test Market Size by Type (2027-2032)
    • 5.3.3 World Prostate Cancer Antigen 3 Test Market Size Market Share by Type (2027-2032)

6 Market Analysis by Application

  • 6.1 World Prostate Cancer Antigen 3 Test Market Size Overview by Application: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Application
    • 6.2.1 Hospital
    • 6.2.2 Diagnosis Center
    • 6.2.3 Other
  • 6.3 Market Segment by Application
    • 6.3.1 World Prostate Cancer Antigen 3 Test Market Size by Application (2021-2026)
    • 6.3.2 World Prostate Cancer Antigen 3 Test Market Size by Application (2027-2032)
    • 6.3.3 World Prostate Cancer Antigen 3 Test Market Size Market Share by Application (2021-2032)

7 Company Profiles

  • 7.1 Hologic
    • 7.1.1 Hologic Details
    • 7.1.2 Hologic Major Business
    • 7.1.3 Hologic Prostate Cancer Antigen 3 Test Product and Services
    • 7.1.4 Hologic Prostate Cancer Antigen 3 Test Revenue, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Hologic Recent Developments/Updates
    • 7.1.6 Hologic Competitive Strengths & Weaknesses
  • 7.2 Thermo Fisher Scientific
    • 7.2.1 Thermo Fisher Scientific Details
    • 7.2.2 Thermo Fisher Scientific Major Business
    • 7.2.3 Thermo Fisher Scientific Prostate Cancer Antigen 3 Test Product and Services
    • 7.2.4 Thermo Fisher Scientific Prostate Cancer Antigen 3 Test Revenue, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Thermo Fisher Scientific Recent Developments/Updates
    • 7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
  • 7.3 MDxHealth
    • 7.3.1 MDxHealth Details
    • 7.3.2 MDxHealth Major Business
    • 7.3.3 MDxHealth Prostate Cancer Antigen 3 Test Product and Services
    • 7.3.4 MDxHealth Prostate Cancer Antigen 3 Test Revenue, Gross Margin and Market Share (2021-2026)
    • 7.3.5 MDxHealth Recent Developments/Updates
    • 7.3.6 MDxHealth Competitive Strengths & Weaknesses
  • 7.4 Exosome Diagnostics GmbH
    • 7.4.1 Exosome Diagnostics GmbH Details
    • 7.4.2 Exosome Diagnostics GmbH Major Business
    • 7.4.3 Exosome Diagnostics GmbH Prostate Cancer Antigen 3 Test Product and Services
    • 7.4.4 Exosome Diagnostics GmbH Prostate Cancer Antigen 3 Test Revenue, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Exosome Diagnostics GmbH Recent Developments/Updates
    • 7.4.6 Exosome Diagnostics GmbH Competitive Strengths & Weaknesses
  • 7.5 Copyright Creative Diagnostics
    • 7.5.1 Copyright Creative Diagnostics Details
    • 7.5.2 Copyright Creative Diagnostics Major Business
    • 7.5.3 Copyright Creative Diagnostics Prostate Cancer Antigen 3 Test Product and Services
    • 7.5.4 Copyright Creative Diagnostics Prostate Cancer Antigen 3 Test Revenue, Gross Margin and Market Share (2021-2026)
    • 7.5.5 Copyright Creative Diagnostics Recent Developments/Updates
    • 7.5.6 Copyright Creative Diagnostics Competitive Strengths & Weaknesses
  • 7.6 Lytech
    • 7.6.1 Lytech Details
    • 7.6.2 Lytech Major Business
    • 7.6.3 Lytech Prostate Cancer Antigen 3 Test Product and Services
    • 7.6.4 Lytech Prostate Cancer Antigen 3 Test Revenue, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Lytech Recent Developments/Updates
    • 7.6.6 Lytech Competitive Strengths & Weaknesses
  • 7.7 YUBO
    • 7.7.1 YUBO Details
    • 7.7.2 YUBO Major Business
    • 7.7.3 YUBO Prostate Cancer Antigen 3 Test Product and Services
    • 7.7.4 YUBO Prostate Cancer Antigen 3 Test Revenue, Gross Margin and Market Share (2021-2026)
    • 7.7.5 YUBO Recent Developments/Updates
    • 7.7.6 YUBO Competitive Strengths & Weaknesses
  • 7.8 MicroDiag Biomedicine
    • 7.8.1 MicroDiag Biomedicine Details
    • 7.8.2 MicroDiag Biomedicine Major Business
    • 7.8.3 MicroDiag Biomedicine Prostate Cancer Antigen 3 Test Product and Services
    • 7.8.4 MicroDiag Biomedicine Prostate Cancer Antigen 3 Test Revenue, Gross Margin and Market Share (2021-2026)
    • 7.8.5 MicroDiag Biomedicine Recent Developments/Updates
    • 7.8.6 MicroDiag Biomedicine Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Prostate Cancer Antigen 3 Test Industry Chain
  • 8.2 Prostate Cancer Antigen 3 Test Upstream Analysis
  • 8.3 Prostate Cancer Antigen 3 Test Midstream Analysis
  • 8.4 Prostate Cancer Antigen 3 Test Downstream Analysis

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Prostate Cancer Antigen 3 Test. Industry analysis & Market Report on Prostate Cancer Antigen 3 Test is a syndicated market report, published as Global Prostate Cancer Antigen 3 Test Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Prostate Cancer Antigen 3 Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,480.00
    		$6,720.00
    		$8,960.00
    		3,463.04
    		5,194.56
    		6,926.08
    		4,170.88
    		6,256.32
    		8,341.76
    		684,051.20
    		1,026,076.80
    		1,368,102.40
    		378,112.00
    		567,168.00
    		756,224.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo